Post-earnings recap
Reported
Thu, May 14, 2026
EPS actual
$-0.86
EPS est.
$-1.07
EPS surprise
+19.63%
1-day move
+8.23%
Celcuity Inc. reported a narrower loss than expected, which contributed to a positive stock reaction, with shares rising by 8.23%. The lack of revenue figures suggests ongoing challenges in generating sales. Investors may view the EPS beat as a sign of improved cost management or operational efficiency.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.86 | $-0.89 | +19.63% |
| Revenue | $0M | $0M | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
Celcuity Inc. is a biotechnology company focused on developing innovative treatments for cancer. With a market cap of $7 billion, it operates in the health care sector, which is increasingly important as new therapies and personalized medicine become more prevalent.
Last quarter
In the last quarter, Celcuity reported an EPS of $-0.73, which was better than the expected $-1.06, resulting in a positive stock reaction of 8.05% the following day. However, there was no revenue reported, which continues to be a concern for investors.
EPS beat streak
6Q
EPS beat rate
75%
Avg EPS surprise
+9.32%
Avg 1-day reaction
+1.56%
Analysts expect Celcuity to report a loss of $-0.89 per share this quarter, with no revenue anticipated. Investors will be keen to see if the company can continue its trend of beating EPS estimates.
Bull case
If Celcuity can beat the EPS estimate again, it may indicate improving operational efficiency and could boost investor confidence, potentially leading to a significant stock price increase.
Bear case
Conversely, if the company fails to meet expectations, it could signal ongoing challenges in its business model, leading to a decline in stock price.
Key metrics to watch
EPS
$-0.89Earnings per share (EPS) is a key indicator of profitability, and investors will be looking to see if the company can narrow its losses.
Revenue
$0MWhile no revenue is expected this quarter, any updates on future revenue potential could impact investor sentiment.
The print will turn on these.
Q1
Will Celcuity's EPS come in better than the expected $-0.89?
A beat on EPS could reinforce the company's improving financial health and boost investor confidence.
Q2
What updates will management provide regarding future revenue potential?
Any insights on future revenue could significantly impact market perception and investor sentiment.
—
Est. EPS
$1.52
Est. Rev
$359M
Impl. Move
±5.6%
Why consensus could be wrong
The consensus may underestimate Celcuity's ability to narrow losses based on its recent trend of beating EPS estimates, despite no revenue.
Supporting evidence
Celcuity has beaten EPS estimates in 75% of the last eight quarters, suggesting a trend of operational improvement.
The stock has shown a positive reaction following EPS beats, indicating that investors may be more optimistic than the current consensus.
The options market is pricing a larger move than historical averages, suggesting that investors expect significant news.
Key risk
If Celcuity reports an EPS significantly better than $-0.89, it could shift market sentiment dramatically.
Pre-commit to what would confirm each case.
This quarter's performance is critical as it will determine whether the recent trend of EPS beats continues and if the company can provide a clearer path to future revenue.
Bull confirmed if
A reported EPS of better than $-0.89 would confirm the bull case.
Bear confirmed if
An EPS worse than $-0.89 would confirm the bear case.
What the market is pricing for the move.
Implied Move
±5.63%
Historical Avg
±4.5%
The options market is pricing in a potential move of about 5.6% in either direction following the earnings report, indicating uncertainty among investors.
Options are pricing ±5.6% while CELC has averaged ±4.5% over the last 8 prints — setup is pricing rich.
ATM IV
1.3%
30d HV
73.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Celcuity beats expectations, history suggests a potential stock increase of around 2.36% on the following day, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may react moderately, reflecting investor caution.
Miss
A miss on EPS could lead to a decline of approximately 2.44% in the stock price, indicating continued investor concern.
The lines on the call that would change the story.